Leuko
Leuko is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
About Leuko
Based in the United States, Leuko is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Leuko develops PointCheck™, a noninvasive, light‑based medical device that images capillary blood flow near the fingernail and uses AI to assess white blood cell levels, intended for at‑home and point‑of‑care monitoring of cancer patients at risk of low white blood cell counts. The device is investigational and supported by clinical studies and NIH/NCI funding.
Explore Leuko's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.